Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Neumora's major depression drug flunks first of three Phase 3 trials
5 months ago
R&D
Roche circles back to China biotech with $80M deal for lung cancer ADC
5 months ago
Deals
R&D
Flagship biotech Valo Health ends 2024 with mid-stage fail
5 months ago
R&D
Pfizer ends work on Sangamo's hemophilia gene therapy, crushing biotech's hopes
5 months ago
R&D
Cell/Gene Tx
Despite mixed data in Alzheimer's agitation, Axsome will still seek FDA approval
5 months ago
R&D
FDA approves subcutaneous version of Bristol Myers' Opdivo
5 months ago
Pharma
FDA+
Novartis ends Phase 1 radiopharma trial; Solve Therapeutics pursues $75M round
5 months ago
News Briefing
BioNTech settles with NIH, UPenn in Covid vaccine disputes and will pay royalties
5 months ago
Pharma
Coronavirus
WuXi AppTec will sell cell and gene therapy business to private equity firm
5 months ago
China
Cell/Gene Tx
Federal appeals court says Teva must delist Orange Book inhaler patents
5 months ago
Pharma
FDA+
CMS explains what went into its first round of drug price negotiations
5 months ago
Pharma
Law
Three drugmakers sue US over 340B discounts to STD clinics they allege don’t qualify
5 months ago
FDA+
Law
Viatris' India-based manufacturing site blocked from shipping 11 generic drugs to US
5 months ago
Pharma
FDA+
Deerfield wins fight to acquire Singular Genomics, beating out Tang Capital’s Concentra
5 months ago
Deals
Diagnostics
Sumitomo’s overactive bladder drug adds another indication
5 months ago
Pharma
FDA+
CagriSema’s weight loss data disappointed. What does Novo do next?
5 months ago
R&D
Jim Wilson's GemmaBio raises $34M to commercialize gene therapies for rare diseases
5 months ago
Deals
Bristol Myers' TYK2 inhibitor succeeds in pair of Phase 3 psoriatic arthritis trials
5 months ago
R&D
PDUFAs for Tonix and Nuvation; Sanofi vaccine partnership; RAPT allergy deal
5 months ago
Deals
News Briefing
Immunology biotech Inmagene to join Nasdaq through reverse merger with what's left of Ikena
5 months ago
Startups
Deals
FDA approves Lilly's Zepbound for sleep apnea, likely cracking open Medicare market
5 months ago
Pharma
FDA+
Novo Nordisk’s once-daily hemophilia drug Alhemo approved in US
5 months ago
Pharma
FDA+
Vertex gets 'vanza triple' approval and Trikafta expansion — with boxed warnings
5 months ago
Pharma
FDA+
2024's biopharma winners and losers; CagriSema falls short; Merck swings China GLP-1 deal; and more
5 months ago
Weekly
First page
Previous page
60
61
62
63
64
65
66
Next page
Last page
